|
|
Volumn 12, Issue 4, 2007, Pages 112-
|
|
Review: Available evidence does not support the use of β blockers as first line treatment for hypertension
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
OXPRENOLOL;
PLACEBO;
ANTIHYPERTENSIVE ACTIVITY;
ANTIHYPERTENSIVE THERAPY;
BINDING AFFINITY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COCHRANE LIBRARY;
CORONARY ARTERY DISEASE;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
EMBASE;
EVIDENCE BASED PRACTICE;
HEART FAILURE;
HUMAN;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
MEDLINE;
MORBIDITY;
MORTALITY;
OUTCOME ASSESSMENT;
SHORT SURVEY;
STROKE;
TISSUE DISTRIBUTION;
UNSPECIFIED SIDE EFFECT;
|
|
EID: 34548227350
PISSN: 13565524
EISSN: None
Source Type: Journal
DOI: 10.1136/ebm.12.4.112 Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|
